01 March 2005 : Original article
Stage-specifically expressed schistosome proteins as potential chemotherapeutic targets
Afaf El-Ansary, Soad Al-DaihanMed Sci Monit 2005; 11(3): RA94-103 :: ID: 15402
Abstract
Digenetic trematodes have evolved behavioral adaptations to their complex life cycles. They have their own strategies to fi nd hosts, locate sites of infection within fi nal and intermediate hosts, escape
immune responses, etc. Many of these strategies are highly complex, but they are sometimes quite subtle. While the mechanisms or processes involved in a few parasites are understood, most are not. Schistosoma mansoni parasites inhabit three distinct environments: water, intermediate molluscan hosts, and a defi nitive vertebrate host. Although targeted chemotherapy and other public health measures are employed to control schistosomiasis and its spread, there is a need for the development of vaccine and new anti-schistosome drugs. Determining how schistosomes interact with different environments may be one mechanism by which suitable vaccine or chemotherapeutic
drugs could be developed. Genes expressed in a stage-specifi c manner may help us to understand the molecular events controlling the complex life cycle of schistosomes. Various proteins are expressed during the life cycle of schistosomes which are essential for its miracidial infection of molluscan hosts, cercarial penetration of vertebrate skin, evasion of the immune responses of both hosts, and other biological activities needed by schistosomes to complete their complex life cycle. Identifying these stage-specifi c proteins may uncover hidden aspects of parasite biology and provide useful leads for the development of novel intervention strategies.
Keywords: Helminth Proteins - antagonists & inhibitors, Helminth Proteins - metabolism, Humans - parasitology, Schistosoma mansoni - growth & development, Schistosoma mansoni - physiology, Schistosomicides - chemistry, Helminth Proteins - metabolism, Host-Parasite Interactions, Humans - parasitology, Life Cycle Stages, Models, Biological, Reverse Transcriptase Polymerase Chain Reaction, Schistosoma mansoni - physiology, Schistosomicides - therapeutic use
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Clinical Research
Preoperative Blood Transfusion Requirements for Hemorrhoidal Severe Anemia: A Retrospective Study of 128 Pa...Med Sci Monit In Press; DOI: 10.12659/MSM.943126
12 Mar 2024 : Clinical Research
Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...Med Sci Monit In Press; DOI: 10.12659/MSM.943500
12 Mar 2024 : Review article
Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive StrategiesMed Sci Monit In Press; DOI: 10.12659/MSM.943240
12 Mar 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe PsoriasisMed Sci Monit In Press; DOI: 10.12659/MSM.943360
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952